Skip to main content

OCR Guidance to Address HIPAA Marketing Turmoil

Written by:  Dianne J. Bourque and Theresa C. Carnegie

In response to a recent lawsuit and outcry from a variety of players in the health care market, the Department of Health and Human Services (“HHS”) has committed to issuing guidance by September 23rd (the compliance date for the Rule) on the drug refill provisions in the HIPAA Omnibus Rule (the “Rule”).  In a joint motion filed September 11th, the plaintiff, Adheris, Inc., and HHS state that “recent developments have obviated any need for the parties to provide further briefing, or for the Court to resolve, plaintiff’s motion prior to September 23, 2013.”  The joint motion also states that HHS will “not enforce the restrictions on remunerated refill reminders and other communications” until November 7th.  We are closely monitoring developments on this complex aspect of the Rule.  Meanwhile, regulated entities should consider waiting for the release of OCR’s guidance before entering into subsidized marketing arrangements.

 

 

Subscribe To Viewpoints

Author

Theresa C. Carnegie is a Mintz attorney who advises health care clients on a wide array of transactional, regulatory, compliance, fraud and abuse matters, and health law issues. She counsels health plans, pharmacy benefit managers, pharmacies, device manufacturers, and distributors.